Greater Cannabis Company (GCAN) Cash from Investing Activities (2020)
Greater Cannabis Company (GCAN) recorded quarterly Cash from Investing Activities of -$36750.0 in Q4 2020, down 47.0% quarter-over-quarter from -$25000.0 in Q1 2020.
Greater Cannabis Company (GCAN) Cash from Investing Activities (2020) Analysis & Trends
Greater Cannabis Company's Cash from Investing Activities history runs 1 years deep, the most recent figure standing at -$36750.0 for Q4 2020.
- In Q4 2020, Cash from Investing Activities changed N/A year-over-year to -$36750.0; the TTM figure through Dec 2020 stood at -$61750.0 (changed N/A YoY), while the FY2020 annual figure was -$61750.0, changed N/A from the prior year.
- Cash from Investing Activities was -$36750.0 for Q4 2020 at Greater Cannabis Company, down from -$25000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$25000.0 in Q1 2020 to a low of -$36750.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.45 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 25.99 Mn |
| 10 | Greater Cannabis Company | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -36,750.00 |
| Dec 31, 2020 | -36,750.00 |
| Mar 31, 2020 | -25,000.00 |
| Mar 31, 2020 | -25,000.00 |